Interleukin (IL) are group of cytokines that are synthesized by lymphocytes, monocytes, macrophages, and other cells. They regulate cell growth, cell differentiation, and cell motility. Fifteen different types of interleukin are present in body. Interleukin inhibitors are immunosuppressive agents that inhibit the action of interleukins. Interleukin inhibitors are used in various conditions including asthma, ankylosing spondylitis, eczema, gout, arthritis (psoriatic and rheumatoid), psoriasis, and systematic sclerosis.
Scope of the Report:
North America is expected to hold a prominent share of the global market, due to rise in the patient pool suffering from psoriasis, arthritis, asthma, and other chronic inflammatory diseases. The presence of well-established drugs makers in North America is further expected to boost the market in the region.
Increase in the prevalence of chronic inflammatory diseases such as arthritis, psoriasis, and asthma is a major factor fueling the global interleukin inhibitors market.
The worldwide market for Interleukin Inhibitors is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
This report focuses on the Interleukin Inhibitors in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Sanofi
GlaxoSmithKline
Novartis
Johnson & Johnson
Roche
Eli Lilly
AstraZeneca
Teva Pharmaceutical
Regeneron Pharmaceuticals
Valeant Pharmaceuticals
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Interleukin 1
Interleukin 2
Interleukin 3
Interleukin 4
Others
Market Segment by Applications, can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
There are 15 Chapters to deeply display the global Interleukin Inhibitors market.
Chapter 1, to describe Interleukin Inhibitors Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Interleukin Inhibitors, with sales, revenue, and price of Interleukin Inhibitors, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Interleukin Inhibitors, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Interleukin Inhibitors market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Interleukin Inhibitors sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Interleukin Inhibitors Introduction
1.2 Market Analysis by Type
1.2.1 Interleukin 1
1.2.2 Interleukin 2
1.2.3 Interleukin 3
1.2.4 Interleukin 4
1.2.5 Others
1.3 Market Analysis by Applications
1.3.1 Hospital Pharmacies
1.3.2 Retail Pharmacies
1.3.3 Online Pharmacies
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Sanofi
2.1.1 Business Overview
2.1.2 Interleukin Inhibitors Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Sanofi Interleukin Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 GlaxoSmithKline
2.2.1 Business Overview
2.2.2 Interleukin Inhibitors Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 GlaxoSmithKline Interleukin Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Novartis
2.3.1 Business Overview
2.3.2 Interleukin Inhibitors Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Novartis Interleukin Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Johnson & Johnson
2.4.1 Business Overview
2.4.2 Interleukin Inhibitors Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Johnson & Johnson Interleukin Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Roche
2.5.1 Business Overview
2.5.2 Interleukin Inhibitors Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Roche Interleukin Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Eli Lilly
2.6.1 Business Overview
2.6.2 Interleukin Inhibitors Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Eli Lilly Interleukin Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 AstraZeneca
2.7.1 Business Overview
2.7.2 Interleukin Inhibitors Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 AstraZeneca Interleukin Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Teva Pharmaceutical
2.8.1 Business Overview
2.8.2 Interleukin Inhibitors Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Teva Pharmaceutical Interleukin Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Regeneron Pharmaceuticals
2.9.1 Business Overview
2.9.2 Interleukin Inhibitors Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Regeneron Pharmaceuticals Interleukin Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Valeant Pharmaceuticals
2.10.1 Business Overview
2.10.2 Interleukin Inhibitors Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Valeant Pharmaceuticals Interleukin Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Interleukin Inhibitors Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Interleukin Inhibitors Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Interleukin Inhibitors Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Interleukin Inhibitors Manufacturer Market Share in 2017
3.3.2 Top 6 Interleukin Inhibitors Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Interleukin Inhibitors Market Analysis by Regions
4.1 Global Interleukin Inhibitors Sales, Revenue and Market Share by Regions
4.1.1 Global Interleukin Inhibitors Sales and Market Share by Regions (2013-2018)
4.1.2 Global Interleukin Inhibitors Revenue and Market Share by Regions (2013-2018)
4.2 North America Interleukin Inhibitors Sales and Growth Rate (2013-2018)
4.3 Europe Interleukin Inhibitors Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Interleukin Inhibitors Sales and Growth Rate (2013-2018)
4.5 South America Interleukin Inhibitors Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Interleukin Inhibitors Sales and Growth Rate (2013-2018)
5 North America Interleukin Inhibitors by Countries
5.1 North America Interleukin Inhibitors Sales, Revenue and Market Share by Countries
5.1.1 North America Interleukin Inhibitors Sales and Market Share by Countries (2013-2018)
5.1.2 North America Interleukin Inhibitors Revenue and Market Share by Countries (2013-2018)
5.2 United States Interleukin Inhibitors Sales and Growth Rate (2013-2018)
5.3 Canada Interleukin Inhibitors Sales and Growth Rate (2013-2018)
5.4 Mexico Interleukin Inhibitors Sales and Growth Rate (2013-2018)
6 Europe Interleukin Inhibitors by Countries
6.1 Europe Interleukin Inhibitors Sales, Revenue and Market Share by Countries
6.1.1 Europe Interleukin Inhibitors Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Interleukin Inhibitors Revenue and Market Share by Countries (2013-2018)
6.2 Germany Interleukin Inhibitors Sales and Growth Rate (2013-2018)
6.3 UK Interleukin Inhibitors Sales and Growth Rate (2013-2018)
6.4 France Interleukin Inhibitors Sales and Growth Rate (2013-2018)
6.5 Russia Interleukin Inhibitors Sales and Growth Rate (2013-2018)
6.6 Italy Interleukin Inhibitors Sales and Growth Rate (2013-2018)
7 Asia-Pacific Interleukin Inhibitors by Countries
7.1 Asia-Pacific Interleukin Inhibitors Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Interleukin Inhibitors Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Interleukin Inhibitors Revenue and Market Share by Countries (2013-2018)
7.2 China Interleukin Inhibitors Sales and Growth Rate (2013-2018)
7.3 Japan Interleukin Inhibitors Sales and Growth Rate (2013-2018)
7.4 Korea Interleukin Inhibitors Sales and Growth Rate (2013-2018)
7.5 India Interleukin Inhibitors Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Interleukin Inhibitors Sales and Growth Rate (2013-2018)
8 South America Interleukin Inhibitors by Countries
8.1 South America Interleukin Inhibitors Sales, Revenue and Market Share by Countries
8.1.1 South America Interleukin Inhibitors Sales and Market Share by Countries (2013-2018)
8.1.2 South America Interleukin Inhibitors Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Interleukin Inhibitors Sales and Growth Rate (2013-2018)
8.3 Argentina Interleukin Inhibitors Sales and Growth Rate (2013-2018)
8.4 Colombia Interleukin Inhibitors Sales and Growth Rate (2013-2018)
9 Middle East and Africa Interleukin Inhibitors by Countries
9.1 Middle East and Africa Interleukin Inhibitors Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Interleukin Inhibitors Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Interleukin Inhibitors Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Interleukin Inhibitors Sales and Growth Rate (2013-2018)
9.3 UAE Interleukin Inhibitors Sales and Growth Rate (2013-2018)
9.4 Egypt Interleukin Inhibitors Sales and Growth Rate (2013-2018)
9.5 Nigeria Interleukin Inhibitors Sales and Growth Rate (2013-2018)
9.6 South Africa Interleukin Inhibitors Sales and Growth Rate (2013-2018)
10 Global Interleukin Inhibitors Market Segment by Type
10.1 Global Interleukin Inhibitors Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Interleukin Inhibitors Sales and Market Share by Type (2013-2018)
10.1.2 Global Interleukin Inhibitors Revenue and Market Share by Type (2013-2018)
10.2 Interleukin 1 Sales Growth and Price
10.2.1 Global Interleukin 1 Sales Growth (2013-2018)
10.2.2 Global Interleukin 1 Price (2013-2018)
10.3 Interleukin 2 Sales Growth and Price
10.3.1 Global Interleukin 2 Sales Growth (2013-2018)
10.3.2 Global Interleukin 2 Price (2013-2018)
10.4 Interleukin 3 Sales Growth and Price
10.4.1 Global Interleukin 3 Sales Growth (2013-2018)
10.4.2 Global Interleukin 3 Price (2013-2018)
10.5 Interleukin 4 Sales Growth and Price
10.5.1 Global Interleukin 4 Sales Growth (2013-2018)
10.5.2 Global Interleukin 4 Price (2013-2018)
10.6 Others Sales Growth and Price
10.6.1 Global Others Sales Growth (2013-2018)
10.6.2 Global Others Price (2013-2018)
11 Global Interleukin Inhibitors Market Segment by Application
11.1 Global Interleukin Inhibitors Sales Market Share by Application (2013-2018)
11.2 Hospital Pharmacies Sales Growth (2013-2018)
11.3 Retail Pharmacies Sales Growth (2013-2018)
11.4 Online Pharmacies Sales Growth (2013-2018)
12 Interleukin Inhibitors Market Forecast (2018-2023)
12.1 Global Interleukin Inhibitors Sales, Revenue and Growth Rate (2018-2023)
12.2 Interleukin Inhibitors Market Forecast by Regions (2018-2023)
12.2.1 North America Interleukin Inhibitors Market Forecast (2018-2023)
12.2.2 Europe Interleukin Inhibitors Market Forecast (2018-2023)
12.2.3 Asia-Pacific Interleukin Inhibitors Market Forecast (2018-2023)
12.2.4 South America Interleukin Inhibitors Market Forecast (2018-2023)
12.2.5 Middle East and Africa Interleukin Inhibitors Market Forecast (2018-2023)
12.3 Interleukin Inhibitors Market Forecast by Type (2018-2023)
12.3.1 Global Interleukin Inhibitors Sales Forecast by Type (2018-2023)
12.3.2 Global Interleukin Inhibitors Market Share Forecast by Type (2018-2023)
12.4 Interleukin Inhibitors Market Forecast by Application (2018-2023)
12.4.1 Global Interleukin Inhibitors Sales Forecast by Application (2018-2023)
12.4.2 Global Interleukin Inhibitors Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Interleukin Inhibitors Picture
Table Product Specifications of Interleukin Inhibitors
Figure Global Sales Market Share of Interleukin Inhibitors by Types in 2017